Pappas Ventures
Jayson Punwani
AssociateParagon Bioservices, Inc.
Marco Chacón
President & CEODebbie James
Executive Vice President - MarketingPATH
Bill Cadwallader
Senior Commercialization Officer DiagnosticsGreg Zwisler
Commercialization OfficerPBM Capital Group
Jayson Rieger
SVP of Business Development & Portfolio ManagementPfizer Venture Investments
Pfizer Venture Investments (PVI) is the corporate venture capital arm of Pfizer and was founded in 2004. PVI has an annual investments budget of $50 million and invests up to $10M per investing round. The firm focuses mainly on U.S. startups but has global reach. PVI attempts to allocate 80% of its funding to U.S. based companies and utilizes the remaining 20% for international ventures. PVI provides equity funding for private companies in need of seed, growth, or venture financing. Remaining opportunistic, PVI focuses entirely on high growth prospects in all sectors and all phases of development. The ideal candidate has a potential for high growth and returns. Additionally, PVI will seek to in-license products and buyout companies if the opportunity arises.
Barbara Dalton
Vice PresidentPharmatek
Pharmatek is a contract development & manufacturing company providing dosage form development & cGMP manufacturing of oral, injectable & topical products. Founded in 1999, our services focus on the rapid advancement of small molecule & peptide drug candidates from the bench to the clinic & include:
· Formulation & Analytical Development
· cGMP Manufacturing
· Clinical Packaging, Labeling & Worldwide Distribution
Our experience includes first-in-man strategies, solutions for poorly soluble compounds, controlled release formulations & separate facilities for the handling of cytotoxic & potent compounds. Pharmatek’s drug delivery technologies include:
· Solid Dispersions
· Particle Size Reduction
· Lipid Delivery
· Complexation
· Lyophilization
· Suspensions & Emulsions
Pharmatek’s 68,000 sq. ft. facility includes 9 class 100,000 cGMP manufacturing suites, formulation & analytical laboratories, & ICH stability storage. Pharmatek has over 150 clients globally, ranging from virtual to large pharmaceutical companies. Having manufactured product for clinical trials in the North America, Europe & Asia; Pharmatek has successfully completed several large pharma quality, EH&S & QP audits.